StockPriceToday
Cintas Corp (CTAS)
About Cintas Corp
Cintas Corporation provides specialized products and services to businesses including uniforms, facility services, first aid and safety supplies, and fire protection services. The company's essential business services have made CTAS stock price sensitive to economic activity levels and business formation trends.
Cintas's uniform rental and sales programs help businesses maintain professional appearance and comply with safety requirements while its facility services include floor mats, restroom supplies, and cleaning products. The company serves customers across various industries.
The company's first aid and safety services help businesses maintain workplace safety while its fire protection services ensure compliance with safety regulations. Cintas's expansion into additional business services demonstrates its strategy for growth, affecting CTAS stock price movements.
Cintas's focus on customer service and operational efficiency has enabled consistent market share growth and profitability. The company's recurring revenue model and defensive business characteristics make it attractive to investors while its market expansion efforts drive continued growth.
CTAS Stock 12 Month Chart
Latest News for CTAS
Shares of Cintas Corp. advanced 7.22% to $206.25 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.51% to 7,533.77 and Dow Jones ...
Cintas stock has more than doubled over the past five years, yet the current checks paint a picture of a company that looks fairly close to its estimated intrinsic value while also screening as ...
Cintas’ fourth-quarter earnings were up 8.9% year-over-year, and full-year revenue hit $11.26 billion.
Other Popular Stocks
Texas Roadhouse Inc. (TXRH) is a restaurant company operating casual dining restaurants known for steaks, ribs, and fresh-made sides, with a lively atmosphere and...
Bioventus Inc. develops and commercializes orthobiologic healing solutions for patients with musculoskeletal conditions.
Spero Therapeutics Inc. (SPRO) is a clinical-stage biopharmaceutical company developing novel therapies to treat multi-drug resistant bacterial infections and rare diseases through innovative drug...